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2 
Abstract 
 
       Metal ions are required for physiologically essential functions such as metalloenzymatic 
reactions, redox reactions, electron transfer, regulation of transcription factor activity, and 
respiration in living cells. Generally, metal ions are homeostatically maintained at very low 
concentrations in the sub-micromolar to micromolar range in living cells. However, some 
organisms, called hyperaccumulators, collect extremely high levels of metal ions, thereby 
providing experimental systems in which to study the mechanisms underlying the selective 
accumulation of metal ions. Typical of such organisms are the ascidians, more commonly known as 
sea squirts or tunicates. They are sessile marine animals belonging to the chordates. Several species 
of ascidians are known to accumulate extremely high levels of vanadium ions in their blood cells. 
Vanadium is usually in the VV state in the natural environment, but in ascidians, most of vanadium 
is reduced to VIII via VIV during the assimilation process. In this review, we first summarize the 
history of the studies on vanadium accumulation in ascidians and then focus on the recent progress 
of molecular studies, especially on the transport and reduction of vanadium, using primarily two 
ascidian species, Ascidia sydneiensis samea and Ciona intestinalis. Several candidate genes for VIV 
transporters and enzymes catalyzing the redox reactions of VV/VIV are addressed in detail. The 
function of accumulated VIII is discussed in relation to redox reactions. 
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Abbreviations 
 
CW, constant-wave; DCT, divalent cation transporter; DTT, dithiothreitol; EDTA, 
ethylenediaminetetraacetic acid; EPR, electron paramagnetic resonance; GR, glutathione 
reductase; GSH, reduced form of glutathione; GSSG, oxidized form of glutathione; NADPH, 
reduced form of nicotinamide adenine dinucleotide phosphate. Nramp, natural 
resistance-associated macrophage protein, XAS; X-ray absorption spectrometry. 
 
1. Introduction 
 
     Metal ions are required for physiologically essential functions such as metalloenzymatic 
reactions, redox reactions, electron transfer, regulation of transcription factor activity, and 
respiration in living cells. Inherent to these functions are the incorporation of metal ions from the 
external environment and their cellular delivery, which are processes dependent on the mechanistic 
properties, regulation, and chemical specificity of the respective metal ion transporters. 
 
     Metal ions in biological systems are generally found as a component of proteins, which are 
known by the general term “metal-related proteins” or “metalloproteins.” Enzymes that contain 
one or more metal ions at an active site are called “metalloenzymes,” which generally harbor one or 
a few transition metal ions that act as a catalytic center (e.g., dehydrogenase, reductase) [1-3]. 
Another function of metal ions is as a structural component at a coordination center (e.g., heme 
protein) [4] or as a structural ligand for amino acid residues in a protein (e.g., Zn finger) [5]. Some 
proteins carry a few or many metal ions or clusters and function as metal carrier proteins, metal 
storage proteins or “metallochaperones” (e.g., ferritin, transferrin) [6-8]. 
 
     Generally, in living cells, metal ions are homeostatically maintained at very low concentrations 
in the sub-micromolar to micromolar range [9-12]. However, some organisms gather extremely 
high levels of metal ions and are called “hyperaccumulators”; these organisms provide 
experimental systems in which to study the mechanisms underlying the selective accumulation of 
metal ions [13-16]. Typical of such organisms are members of the ascidians, sessile marine animals 
more commonly known as sea squirts or tunicates, belonging to the phylum Chordata. The 
ascidians make good model systems for biological metal redox reactions because vanadium is 
usually in the +5 state (HVO42- or H2VO4-; VV) in the natural environment but most of vanadium is 
reduced to the +3 state (V3+; VIII) via the +4 state (VO2+; VIV) during assimilation and 
hyperaccumulation by the ascidians. 
 
2. Vanadium accumulation in ascidians 
 
2.1. Discovery of high levels of vanadium accumulation 
 
     About a hundred years ago, the German physiological chemist Martin Henze discovered high 
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levels of vanadium in the blood (coelomic) cells of the ascidian Phallusia mammillata, collected 
from the Bay of Naples [17]. His discovery attracted the interdisciplinary attention of chemists, 
physiologists, and biochemists, in part because of considerable interest in vanadium as a possible 
prosthetic group, in addition to iron and copper, in respiratory pigments. This would have implied a 
role for vanadium in oxygen transport, a hypothesis that later proved to be false [18]. After Henze's 
finding, many chemists looked for vanadium in other species of ascidians.  
 
     The concentration of vanadium within the tissues of many ascidians has been determined by 
neutron activation analysis, electron paramagnetic resonance (EPR), or atomic absorption 
spectrometry. Ascidians belonging to the suborder Phlebobranchia appear to contain higher levels 
of vanadium than those of the suborder Stolidobranchia [19]. Of the tissues examined, blood cells 
contain the highest amounts of vanadium. The highest amount was found in blood cells of the 
ascidian Ascidia gemmata (Fig. 1). The vanadium concentration in this species can reach 350 mM 
[19, 20], which is 107 times the concentration found in seawater (35 nM) [21, 22]. This is thought to 
be the highest degree of accumulation of a metal in any living organism.  
 
     The accumulation of vanadium is also found in the fan worms Pseudopotamilla occelata [23] 
and Perkinsiana littoralis [24]. In these fan worms, the concentration of vanadium is as high as 60 
mM. Fan worms belong to the phylum Polychaeta, which is phylogenetically distant from 
Chordata. Unlike the chordates, in fan worms, the highest level of vanadium is found not in blood 
(coelomic) cells but in the epithelial cells of the branchial crown. We previously reported that the 
same antigenic signal as Vanabins (see Section 3.2) was found in P. occelata [25], but the 
molecular nature is unclear.  
 
2.2. Identification of vanadocytes 
 
     Ascidian blood cells can be classified into 9–11 different types, which are grouped into six 
categories on the basis of their morphology: hemoblasts, lymphocytes, leukocytes, vacuolated cells, 
pigment cells, and nephrocytes [26]. The vacuolated cells can be further divided into at least four 
different types: morula cells, signet ring cells, compartment cells, and small compartment cells.  
 
     For many years, morula cells were thought to be the vanadium-containing cells, or vanadocytes 
[27-30]. These cells have a pale green color resembling that of an aqueous solution of vanadium, 
and their dense granules, which can be observed under an electron microscope after fixation with 
osmium tetroxide, were assumed to be vanadium deposits. At the end of the 1970s, scanning 
transmission electron microscopes with energy dispersive X-ray detectors became available, and 
the finding was made that the characteristic X-ray due to vanadium was detected not from morula 
cells, but from granular amoebocytes, signet ring cells, and type-II compartment cells [31-33]. 
Complementary to the X-ray microanalytical research, the chelating reagent 2,2’-bipyridine, which 
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is known to complex with vanadium in the +3 oxidation state [34], was successfully used as a 
VIII-specific staining agent to visualize VIII in the blood cells of P. mammillata and Phallusia 
fumigata [35, 36]. Another analytical approach used was the direct measurement of vanadium in 
each type of blood cell. Using density-gradient centrifugation to separate the specific types of 
blood cells, followed by thermal neutron-activation analysis to quantify vanadium in the isolated 
subpopulations of blood cells, vanadium was found to be accumulated in signet ring cells in 
Ascidia ahodori [37]. However, all of these approaches have limitations due to the freezing/drying 
steps, specificity, and purity, all of which affect the conclusiveness of the results. 
 
     In 2001, we used an X-ray microscope installed at beamline 21 of the European Synchrotron 
Radiation Facility to visualize vanadium in living blood cells of P. mammillata and Ascidia 
sydneiensis samea [38]. Without fixation, freezing or staining, we observed vanadium localized in 
the signet ring cells and vacuolated amoebocytes of two vanadium-rich ascidian species. A 
combination of transmission and fluorescence imaging of signet ring cells suggested that the 
vacuoles of both species contained vanadium. An X-ray beam with an energy of 5.500 keV was 
used to obtain good yields of vanadium transmission and fluorescence. At this energy, vanadium 
ions at the +3, +4, and +5 oxidation states were detected simultaneously. 
 
2.3. Vanadium, protons, and sulfate in vanadocytes 
 
     Henze [17], in addition to discovering the very high levels of vanadium in the blood cells of 
ascidians, also reported that the homogenate of the blood cells was extremely acidic [17, 39-41]. 
This unusual phenomenon attracted the interest of investigators because of the possible role of the 
highly acidic environment in changing or maintaining redox potentials.  
     The reported pH values varied considerably. It is probable that one of the reasons for the 
variation in pH values is that the measurement of pH has been made without fractionation of the 
population of blood cells. Thus, we designed a study to isolate the acidic blood cells from among 
several types of blood cell and to examine whether the acidic blood cells were identical to the 
vanadocytes [20].  
     From microelectrode measurements of blood cell lysate, and non-invasive ESR measurements 
on intact cells under anaerobic conditions, we found that A a correlation exists between the 
concentration of VIII ions and the pH within the vacuoles of three Ascidia species. In A. gemmata, 
which contains the highest concentration of vanadium (350 mM), the vacuoles have the lowest pH 
of 1.86. Vacuoles of A. ahodori, containing 60 mM vanadium, have a pH of 2.67, and those of A. 
sydneiensis samea, containing 13 mM vanadium, have a pH of 4.20 [20] (Table 1). 
 
     In general, vacuolar-type H+-ATPases (V-ATPases) play a central role in pH homeostasis in 
various intracellular organelles, including vacuoles, clathrin-coated vesicles, endosomes, 
lysosomes, Golgi-derived vesicles, multivesicular bodies, and chromaffin granules, which belong 
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to the central vacuolar system [42-44]. The proton-motive force generated by V-ATPases in these 
organelles is used to drive transport processes. 
 
     By immunocytological analysis, subunits A and B of V-ATPase were found to be localized on 
the vacuolar membrane of the vanadocytes in A. sydneiensis samea, and inhibition of the proton 
pump by bafilomycin A, which specifically inhibits V-ATPases, resulted in pH neutralization of the 
vacuoles [45]. The cDNAs for subunits A, B, and C were cloned from A. sydneiensis samea, and a 
functional study by a yeast complementation assay was performed [46, 47]. As a follow-up to these 
studies, a functional assay to examine whether the protons concentrated by V-ATPase are linked to 
the accumulation of vanadium should be conducted. 
 
     A considerable amount of sulfate has always been found in association with vanadium in 
ascidian blood cells [31-33, 48-52], suggesting that sulfate might be involved in the biological 
function and/or the accumulation and reduction of vanadium ions. Table 1 summarizes the results 
of measurements of sulfate ion concentrations in ascidian blood cells. The concentration of sulfate 
ions in the blood cells of A. gemmata is 500 mM, which suggests that VIII (350 mM) and sulfate 
ions coexist as counterions in the vacuole [53] (the ideal ratio of VIII ions to sulfate ions, existing as 
counterions, is 1:1.5). Frank et al. reported the concentration of sulfate ions to be 250 mM in the 
blood cells of Ascidia ceratodes [54]. We determined the sulfate and vanadium concentrations in 
blood cells (except for giant cells) in A. sydneiensis samea to be 38 mM and 86 mM, respectively; 
although the ratio is not exactly 1:1.5,  the concentrations are still within an appropriate range for 
their existence as counterions  [55]. Sulfate ions incorporated in ascidian blood cells exist as 
complex cations with VIII ions, such as [VIII(H2O)5(HSO4)]2+ [50, 51]. 
 
     Sulfate ions are very important constituents in biological systems, and sulfate ion transporters 
are known from a wide range of organisms [56]. Recently, we isolated a homolog of sulfate-ion 
channels, AsSUL1, from the blood cells of A. sydneiensis samea [55]. Functional analysis of 
AsSUL1 revealed that it could act as a sodium-dependent sulfate transporter when expressed in 
Xenopus laevis oocytes (Fig. 2A). Because the sodium concentration in the blood plasma of A. 
sydneiensis samea is very high, one can reasonably suppose that AsSUL1 is a plasma membrane 
sulfate transporter in blood cells of the ascidians. The Km value for sulfate was 1.75 mM (Fig. 2B), 
which is sufficiently less than the 25 mM concentration of sulfate ions in the blood plasma of A. 
sydneiensis samea [55] so that AsSUL1 should be functional as an active transporter. Considering 
these observations, we hypothesize the accumulation pathway of vanadium, sulfate, and protons in 
ascidians to be as depicted in Fig. 3.  
 
     In general, the cytoplasm is the major compartment in the cell where metal ions exert their 
physiological functions. The concentration of free metal ions in the cytoplasm is strictly regulated, 
primarily by membrane transporters involved in uptake and export. Metal-binding proteins can 
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absorb excess metal ions to control the free metal ion concentration, or to stabilize metal ions, in 
the cytoplasm. Compartmentalization of metal ions into organelles decreases the concentration of 
free metal ions in the cytoplasm and also acts as a reservoir of metal ions, without affecting the 
physiological function of the ions in the cytoplasm.  
 
     In vanadocytes, the concentration of vanadium is extremely high, and most of the vanadium is 
reduced to VIII. VIII-aqua ions are only stable at low pH, and the acidic vacuole is the most suitable 
compartment for storage of VIII ions. VV ions outside the cell are transported into the cytoplasm and 
reduced to VIV. VIV-aqua ions are also stable at low pH, but the cytoplasm is not. Therefore, 
VIV-binding proteins must exist in the cytoplasm to absorb and stabilize VIV ions at physiological 
pH. Reducing agents must participate in the accumulation of vanadium in vanadocytes, since the 
reduction of VV to VIV and/or VIV to VIII is presumed to accelerate this accumulation. 
 
3. Vanadium transport and reduction 
 
3.1. Transport of VV into the cytoplasm 
 
     As Dingley et al. [57] pointed out, the phosphate anion transporter is a candidate for the specific 
transporter of VV ions, since the chemical features of VV ions (HVO2– or H2VO4–) resemble those 
of phosphate anions (HPO42– or H2PO4–). We are currently attempting to identify homologs of 
NaPi- or PiT-type phosphate transporters in blood cells and other tissues of A. sydneiensis samea. 
Such anion transporters may be involved in the first step(s) of vanadium uptake in the branchial sac 
or the intestine. 
 
     Another possible pathway of VV ion transport is a transferrin (Tf)–transferrin receptor 
(TfR)-like pathway, as is known for iron homeostasis in mammals [11, 58]. Tf–TfR-mediated 
endocytosis is the major pathway by which all cells take up FeIII ions, which is released from 
transferrin in the acidified endosome. The released FeIII ions are reduced to FeII by a member of the 
STEAP metalloreductase family (STEAP3 in the erythroblast) and transported out of the endosome 
by Nramp/DCT/DMT [59]. 
 
     In mammals, transferrin is reported to transport VIV ions. The average vanadium concentration 
in human blood serum is 200 nM, with most of the vanadium associated with the plasma fraction, 
while that in tissues reaches 6 M [61]. The first report of VIV binding to human transferrin was by 
Cannon and Chasteen [62], and more recent work has extended the studies on VV–Tf interactions 
[63]. Also, the distribution of insulin-mimicking vanadium compounds in blood plasma are 
extensively studied in relation to their interaction with Tf [64, 65]. 
 
     Transferrin homologs have already been cloned from three ascidian species, A. sydneiensis 
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samea [60], Halocynthia roiretzi [66], and Ciona intestinalis [67], although TfR gene is not found 
in ascidians [68]. Functional analyses suggested that H. roretzi transferrin binds to FeIII [66], while 
one of the two C. intestinalis transferrin binds to both FeIII and VV [69-71]. These transferrins are 
monolobal transferrins that are unique to ascidians. 
 
     In A. sydneiensis samea, two vanadium-binding proteins that are expressed in blood plasma 
have been identified. One is a member of the Vanabin family, VanabinP. Recombinant VanabinP 
binds a maximum of 13 VIV ions per molecule, with a Kd of 2.8 × 10–5 M [72]. Another one is 
VBP-129, which binds to VIV ions, as well as to FeIII, CoII, CuII, and ZnII ions [73]. The 
mechanisms by which VanabinP and VBP-129 capture vanadium in the blood plasma and 
subsequently transfer the vanadium ions are the next problems to be resolved. 
 
3.2. Reduction of VV to VIV in the cytoplasm 
 
     NADPH is a strong candidate for the reductant involved in the conversion of VV to VIV because 
the enzymes involved in the pentose phosphate pathway are expressed exclusively in the cytoplasm 
of vanadocytes in A. sydneiensis samea [74-77]. Detailed in vitro studies have suggested that the 
reduction of VV to VIV occurs with the assistance of several chelating substances [78, 79]. 
Biologically relevant thiols, such as glutathione (GSH) and cysteine, are also candidates for the 
direct reductant of VV to VIV [80]. 
 
     Recently, we revealed that the vanadium-binding protein, Vanabin2, catalyzes the reduction of 
VV to VIV in the presence of NADPH, glutathione reductase (GR), and GSH [81]. Without 
Vanabin2, the reduction proceeds at a very slow rate. Rapid reduction was observed after the 
addition of 4 μM Vanabin2 to 0.1–10 mM VV in the presence of 2 mM GSH, 200 μM NADPH and 
0.25 U/ml GR (Fig. 4).  
 
     Vanabin2 was first isolated from A. sydneiensis samea as a novel vanadium-binding protein by 
anion exchange column chromatography [82]. In this species, the Vanabin family consists of at 
least five closely related proteins, Vanabins 1–4 and VanabinP [72, 83, 84]. All of these five 
Vanabins possess 18 cysteine residues, and the intervals between cysteines are very well conserved 
(Fig. 5A). In vitro studies indicate that nine disulfide bonds are partially cleaved by 1–4 mM GSH, 
forming intermediate structures [81]. This suggests that electrons may be transferred from the 
donor NADPH to the acceptor VV ions via thiol–disulfide exchange reactions in Vanabin2. The 
resultant disulfides in Vanabin2 are converted to thiols by reduced GSH, and the oxidized GSH is 
re-reduced by GR. The disulfides of GR are reduced to thiols by NADPH [85], which is linked to 
the pentose phosphate pathway. Since the concentration of GSH is 1.83 mM in vanadocytes of A. 
sydneiensis samea [81], the existence of a redox cascade from NADPH to VV ions in ascidians is 
likely. 
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     In our model, VV ions are readily reduced to VIV in the cytoplasm, and VIV ions are stabilized by 
Vanabins, which act as both vanadium reductases and vanadium chaperones. Two of the 
cytoplasmic Vanabins in A. sydneiensis samea, Vanabin1 and Vanabin2, bind up to 10 and 20 VIV 
ions, with dissociation constants of 2.1  10–5 M and 2.3  10–5 M, respectively, in Tris buffer at pH 
7.4 and 20°C [83]. NMR titration experiments showing the 1H–15N heteronuclear single-quantum 
coherence (15N HSQC) spectra of Vanabin2 upon the gradual addition of VIV ions revealed the 
putative vanadium-binding sites on Vanabin2 [86]. The resonances of 32 residues were quenched 
or disappeared, implying that these residues are located near the VIV interaction sites (Fig. 5B).The 
locations of the residues involved in the VIV interaction sites agree well with the positively charged 
areas in the electrostatic potential plot, where basic residues are gathered. X-band CW EPR studies 
revealed that the VIV–Vanabin2 complex invariably exhibits a usual mononuclear-type VIV signal 
up to a 20:1 molar ratio of VIV:Vanabin2, and no allosteric effects were observed in the process of 
binding multiple vanadium ions [87].  A two-pulse ESEEM study suggested that most EPR-active 
VIV ions have amine nitrogen ligands. This suggests that all or almost all amine nitrogens are used 
in the vanadium-saturated Vanabin2 because the EPR-active vanadium number is 20, while 
Vanabin2 has 15 amine nitrogens (14 lysines and one N-terminal amine). 
 
     The mechanism of metal selectivity in Vanabins has not been determined, although the effects 
of acidic pH on selective metal binding and on the secondary structure of Vanabin2 was studied 
[88]. Using immobilized metal ion affinity chromatography (IMAC), Vanabin2 was shown to 
selectively bind VIV, FeIII, and CuII ions under acidic conditions. In contrast, CoII, NiII, and ZnII ions 
were bound at pH 6.5 but not at pH 4.5. Changes in pH had no detectable effect on the secondary 
structure of Vanabin2 under acidic conditions, as determined by CD spectroscopy. Little variation 
in the dissociation constant for VIV ions was observed in the pH range 4.5–7.5, suggesting that the 
binding state of the ligands is not affected by acidification. Taken together, these results suggest 
that the reason for metal ion dissociation upon acidification is not because of a change in secondary 
structure but rather because of protonation of the amino acid ligands that complex with the VIV ions 
[88]. 
 
     Site-directed mutagenesis of Vanabin2 has been performed to reveal the functional contribution 
of each binding site. We prepared several mutants of Vanabin2 by in vitro site-directed mutagenesis 
and analyzed their metal selectivity and affinity by IMAC and the Hummel–Dreyer method [89]. 
Mutation at K10/R60 (Site 1) markedly reduced the affinity for VIV ions. Mutation at 
K24/K38/R41/R42 (Site 2) decreased the maximum binding number, but only slightly increased 
the overall affinity for VIV ions. Mutation of disulfide bonds near Site 1 did not affect the protein’s 
high-affinity binding capacity, while those near Site 2 decreased the overall affinity for VIV ions. 
These results suggest that Site 1 is a high-affinity binding site for VIV ions, while Site 2 is a 
moderate affinity site for multiple VIV ions (Fig. 5B). Therefore, we propose that VV is reduced to 
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VIV by thiol–disulfide exchange reactions using cytoplasmic Vanabins as reductase, with the 
resultant VIV ions bound to the Vanabins and stabilized in the cytoplasm. 
 
     Vanabin2 is a very abundant protein in the cytoplasm of vanadocytes in A. sydneiensis samea. 
Recently, we extensively examined the sequence variation of Vanabin2 and identified five variants 
of Vanabin2 [90]. The lengths of the open reading frames of these variants were identical to that of 
Vanabin2, although the amino acid sequences encoded by the cDNA clones differed from the 
Vanabin2 sequence at 1, 9, 10, or 14 positions. All of the 18 cysteine residues were conserved. 
Using IMAC, we found that Vanabin2 and the most divergent one of the five variants, named 14MT, 
which differs from Vanabin2 at all 14 positions, have the same metal ion selectivity [90]. These 
results suggest that sequence variations have been under strict evolutionary constraints, with the 
high-affinity binding sites for VIV ions conserved among all the Vanabin2 variants. We speculate 
that gene duplication of Vanabin2 may account for the very high degree of vanadium accumulation. 
 
     A homology search of public DNA and protein databases, using both the Vanabin1 and 
Vanabin2 amino acid sequences, revealed no proteins with striking similarities, other than from 
two ascidian species, Ciona intestinalis and Ciona savignyi. We identified five Vanabins 
(CiVanabin1 to CiVanabin5) from C. intestinalis [91], the whole genome of which has been 
sequenced [92]; we have reported that these CiVanabins bind VIV ions. Two of them, CiVanabin1 
and CiVanabin2, have a long C-terminal domain, the function of which is still unclear, that is rich in 
aspartic and glutamic acids. We have also found five Vanabin homologs from the related species C. 
savignyi, although its genome assembly is still incomplete 
(http://www.broad.mit.edu/annotation/ciona/index.html). In addition, expressed sequence tag 
(EST) analysis yielded several Vanabin homologs in A. gemmata, which accumulates the highest 
levels of vanadium ions (Samino et al., unpublished data). Vanabins therefore seem to be 
ubiquitous among the vanadium-accumulating ascidians and may hold the key to resolving the 
mechanism underlying the highly selective accumulation of vanadium ions. 
 
3.3. Transport of VIV into the vacuole 
 
     As described in Section 2.3, the pH of the vanadocyte vacuole is kept extremely low by 
V-ATPase. We hypothesized that a proton gradient generated by V-ATPase provides the energy to 
transport vanadium across the vacuolar membrane. To test this hypothesis, we cloned a cDNA 
encoding a member of the Nramp/DCT1 family from vanadocytes of A. sydneiensis samea because 
the Nramp/DCT1 family is known to transport a broad range of divalent cations (FeII, CuII, ZnII, 
MnII, CdII, CoII, NiII, and PbII ions) across the membrane using a proton gradient as the motive force 
[93, 94]. We found that the product of this gene, AsNramp, is localized on the vacuolar membrane 
and operates as an antiporter of VIV ions and H+ ions. In contrast, a rat homolog of Nramp/DCT, 
rDCT1, could not transport VIV under any of the conditions examined (Ueki et al., unpublished 
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data). The results of this study indicated that AsNramp is a VIV/H+ antiporter expressed on the 
vacuolar membrane of vanadocytes. These findings support the proposed model holding that a 
proton electrochemical gradient generated by V-ATPase is the driving force for VIV transport from 
the cytoplasm into the vacuole. 
 
     The direction of transport and metal selectivity is well studied for mammalian Nramps. Nramp2 
is reported to be a proton/divalent cation symporter that uses a proton electrochemical gradient as 
an energy source. Transport studies using Xenopus oocytes or mammalian cell lines indicated that 
Nramp2 transports a broad range of divalent cations, including FeII, ZnII, CdII, MnII, CuII, and CoII, 
but not CaII or MgII ions, in a pH-dependent manner [95]. In contrast, the direction of proton/metal 
transport by Nramp1 is controversial. One study used Xenopus oocytes to examine metal transport 
by Nramp1 and revealed that Nramp1 acts as an antiporter for protons and the divalent cations FeII, 
ZnII, and MnII ions [96]. The antiport activity and vacuolar localization of AsNramp are similar to 
that of mammalian Nramp1. 
 
     Another candidate protein for vanadium transport is a P-type metal ATPase, which is able to 
import or export heavy metal ions into cellular organelles. P-type ATPases are classified into 12 
types, depending on the primary amino acid sequence and substrate specificity [97, 98]. The heavy 
metal-transporting P1B-type ATPases (metal ATPases) typically possess one to six metal-binding 
domains (MBDs) in the N-terminal region of the protein. These MBDs allow the transport of 
monovalent and divalent transition metal ions such as CuI, CuII, CoII, ZnII, CdII, and PbII ions, either 
into cellular organelles or out of the cell [99]. We recently cloned the cDNA for a P1B-type ATPase, 
AsHMA1, from blood cells of A. sydneiensis samea and are now examining its metal selectivity 
and transport activity (Ueki et al., unpublished data).  
 
3.4. Reduction of VIV to VIII in the vacuole 
 
     In ascidians, VIV is further reduced to VIII. Several candidates have been suggested as reductants 
of VIV [100]. Among them, the potential biologically relevant reducing agents include cysteine 
complexes. Frank et al. reported that large quantities of intracellular sulfate, as well as aliphatic 
sulfonic acids such as cysteic acid, are present in ascidian blood cells [49, 50]. Since cysteic acid is 
an oxidation product of cysteine, cysteine may be the reducing agent responsible for the reduction 
of VIV to VIII in ascidians. If cysteine does function as a reducing agent in ascidians, some biogenic 
ligands promoting the reduction of VIV are expected to participate in the reaction. Although 
cysteine by itself cannot reduce VIV to VIII, cysteine methyl ester was reported to reduce VIV to VIII 
with the assistance of EDTA and EDTA-like ligands of aminopolycarboxylate in water [101]. 
Glycylhistidine and glycylaspartic acid are two biological ligands that were shown to assist the 
reduction of VIV to VIII by cysteine methyl ester [79].  
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     XAS studies have suggested the reduction of VV to VIII in a single coordination environment 
[102, 103]. A new complexed form of [VIVO(EDTA)]– was observed, with an increase in the 
amount of [VIII(H2O)6]3+ in blood cells of A. ceratodes exposed to DTT plus VIVO2+ ions. The 
proposal was made that two reduction steps from VV to VIII can occur sequentially in an EDTA-like 
7-coordinate ligand array under mild cytoplasm-like conditions of an aqueous pH 6.5 solution. 
This model is suggestive of the reaction mechanism and the structure of the active center of 
vanadium reductase. Glutamic acid and aspartic acid residues of Vanabins could provide such a 
coordination environment, although our model (Section 3.2) based on the identification of 
AsNramp is apparently inconsistent with the model. Frank et al. [103] suggested the presence of 
VIII transporter on the vacuolar membrane, and search for such transporter is necessary to 
substantiate the model. 
 
3.5. Regulation of intracellular vanadium via the glutathione pathway 
 
     The draft genome of an ascidian species, C. intestinalis, has been read and inferred to contain 
approximately 16,000 protein-coding genes.  The cDNAs for transcripts of 13,464 genes have been 
characterized and compiled as the “Ciona intestinalis Gene Collection Release I” [92, 104, 105]. 
This species is known to accumulate up to 0.6 mM vanadium in its blood cells [19] and is therefore 
a good model organism to study vanadium accumulation.  
 
     We recently performed microarray experiments to identify genes that are regulated by excess 
vanadium ions in C. intestinalis. The overall change in gene expression was similar between VIV- 
and VV-treated individuals, but the responses were not identical. Among the major metabolic 
pathways, expression of enzymes in the glutathione-related pathway was significantly affected by 
VIV-treatment. This response was further examined using reverse-transcription polymerase chain 
reaction (RT-PCR) from the perspective of redox activity and accumulation of metal ions in each 
tissue (Kume et al., unpublished data). Excess vanadium ions could induce the glutathione-related 
pathway in C. intestinalis to stabilize the vanadium concentration in tissues or cells. Another 
possible regulator of vanadium ion concentration is the GS-X pump, which plays an important role 
in the excretion or compartmentalization of excess metal ions, such as CdII or PtII [106, 107]. The 
vanadyl–glutathione conjugate could be a possible target of the export pathway [108, 109]. Adamis 
et al. [110] reported that CdII activates -GT and glutathione transferase2 (GST2) in yeast and that 
this activation is necessary for the regulation of cytoplasmic CdII levels, the recycling of glutamate, 
and regeneration of GSH. Similar mechanisms could act in C. intestinalis to regulate the 
concentration of vanadium in each tissue. 
 
4. Function of accumulated VIII 
 
     Although the unusual phenomenon whereby some ascidians accumulate vanadium to levels 
 
13 
more than 10 million times higher than those in seawater has attracted researchers in various fields, 
the physiological role(s) of vanadium remains to be explained. Endean [27, 111, 112] and Smith 
[113, 114] proposed that the cellulose of the tunic might be produced by vanadocytes. Carlisle 
[115] suggested that vanadium-containing vanadocytes might reversibly trap oxygen under 
conditions of low oxygen tension. However, no direct evidence exists in support of these 
hypotheses [18]. Also, vanadium was proposed to protect ascidians from fouling or predation, or 
act as an antimicrobial agent [116-118]. Antifouling and anti-predation are the most relevant 
physiological function of acid contained in the tunic, but the contribution of vanadium for these 
functions is not conclusive [119, 120]. 
 
     Since we have suggested that Vanabin2 catalyzes a redox cascade connecting NADPH to 
VV/VIV, one should consider whether the reverse reactions, accompanying the oxidations of VIII to 
VIV and VIV to VV, occur in the proposed cascade, perhaps resulting in the release of energy, just 
like the vanadium redox flow battery [121]. Thus, the ascidians may accumulate the metal ions as 
an energy source. 
 
     A more comprehensive survey for the function of vanadium could be achieved by mutational 
analysis to find an ascidian strain that cannot accumulate vanadium. In C. intestinalis, such an 
approach is available by using transposon mutagenesis [122-124]. 
 
5. Conclusion and perspectives 
 
     The accumulation, reduction, and transport of vanadium ions are expected to be tightly linked. 
The ascidians that accumulate extremely high levels of vanadium in a reduced form, VIII make 
good model systems. The physiological function of accumulated vanadium ions in a reduced form, 
VIII, is presumably exerted through redox-coupled reactions. An analysis of vanadium reductase 
and vanadium transporters should provide the key to understand the function of vanadium in 
ascidians. The study of vanadium assimilation in ascidians should also provide a fundamental 
insight into the physiological roles of vanadium, not only in ascidians but also in mammals, in 
which vanadium is an essential element [125]. 
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     Table 1. Correlations among vanadium concentration, pH, and sulfate in ascidian blood cells. 
Species tissue vanadium pH sulfate ref. 
Ascidia gemmata whole blood cells 350 mM 1.86 500 mM [20] 
Ascidia ahodori whole blood cells 60 mM 2.67 N. D. [20] 
Ascidia sydneiensis 
samea 
whole blood cells 13 mM 4.20 N. D. [20] 
blood cells without 
giant cells 
38 mM N. D. 86 mM [55] 
Ascidia ceratodes whole blood cells 99 mM 1.8 0.25 M [54] 
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Figure Legends 
 
 
     Fig. 1. Ascidia gemmata, the most vanadium-rich ascidian species found so far. A specimen 
collected at Mukaishima Marine Biological Laboratory, Hiroshima, Japan. 
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     Fig. 2. Specificity of AsSUL1 expressed in Xenopus oocytes. (A) Na+ dependency of sulfate 
uptake by AsSUL1. Oocytes were injected with (solid bars) or without (white bars) AsSUL1 
mRNA and incubated for 3–5 days before the uptake experiment. Sulfate uptake was examined in 
the presence (+) or absence (–) of 100 mM sodium chloride or choline chloride at 21°C. The initial 
sulfate concentration was 1 mM. (B) Kinetic properties of AsSUL1. Sulfate uptake was measured 
with increasing concentrations of sulfate in the uptake buffer containing 100 mM NaCl. Each data 
point represents the mean value for three experiments. The Km and Vmax of AsSUL1 were 1.75 mM 
and 2500 pmol/oocyte/h, respectively. Reproduced from [55] with permission from the copyright 
holders. 
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     Fig. 3. (A) General scheme of homeostatic regulation of concentrations of metal ions and other 
substances in a cell. (B, C) Putative pathway of vanadium accumulation and the concentration of 
vanadium, sulfate, and protons in Ascidia gemmata (B) and A. sydneiensis samea (C). 
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     Fig. 4. (A) VV reduction by Vanabin2 observed by EPR spectrometry. Spectrum 1, 1 mM VV; 
Spectrum 2, addition of 2 mM GSH to 10 mM VV 24 h after incubation at room temperature; 
Spectrum 3, after 24 h incubation of 10 μM Vanabin2, with a reaction mixture of 10 mM VV and 2 
mM GSH at room temperature. The signal intensities are given as relative values. (B) VV reduction 
by Vanabin2 observed by coupled NADPH oxidation assay. The vertical axis indicates the level of 
NADPH oxidation after 60 min. Light gray bar, the amount of NADPH oxidation in the absence of 
both VV and Vanabin2; dark gray bar, that in the presence of 4 μM Vanabin2; white bars, that in the 
presence of 0.1–2.5 mM VV; black bars, that in the presence of both 4 μM Vanabin2 and 0.1–2.5 
mM VV. Reproduced from [81] with permission from the copyright holders. 
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     Fig. 5. Three-dimensional structure of Vanabin2 (PDB ID: 1vfi) and the mutated sites in ref. 
[89]. (A) Ribbon model of Vanabin2. Nine disulfide bonds are indicated (SS1–9). The cysteine 
residues in two sites were mutated (shown by dotted rectangles). (B) Spherical model of Vanabin2. 
Possible VIV-binding sites are shown in yellow and are denoted by amino acid numbers on the two 
faces, looking in opposite directions [86]. The three boxed residues were mutated in ref. [89]. 
Reproduced from the original color figure for [89] with permission from the copyright holders. 
 
 
 
